Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Retallack

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Australasian Physical & Engineering Sciences in Medicine|July 1, 1983
Quantitative in-vivo determination of bone mineral using computerized roentgenographic densitometryR I Price, R W Retallack, D H Gutteridge, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Effect of pregnancy and lactation on maternal bone mass and calcium metabolismG N Kent, R I Price, D H Gutteridge, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?D H Gutteridge, G N Kent, R L Prince, et al.
Bone|February 10, 1999
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodiumG O Stewart, D H Gutteridge, R I Price, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1990
Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaningG N Kent, R I Price, D H Gutteridge, et al.
Clinical Endocrinology|March 1, 1991
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesA J Fenton, D H Gutteridge, G N Kent, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodiumR I Price, D H Gutteridge, B G Stuckey, et al.
Seminars in Arthritis and Rheumatism|February 1, 1994
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severityB G Stuckey, D H Gutteridge, G O Stewart, et al.
Bone|October 1, 1996
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year studyD H Gutteridge, R W Retallack, L C Ward, et al.
Bone|February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical boneD H Gutteridge, R W Retallack, L C Ward, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Australasian Physical & Engineering Sciences in Medicine|July 1, 1983
Quantitative in-vivo determination of bone mineral using computerized roentgenographic densitometryR I Price, R W Retallack, D H Gutteridge, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Effect of pregnancy and lactation on maternal bone mass and calcium metabolismG N Kent, R I Price, D H Gutteridge, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?D H Gutteridge, G N Kent, R L Prince, et al.
Bone|February 10, 1999
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodiumG O Stewart, D H Gutteridge, R I Price, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1990
Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaningG N Kent, R I Price, D H Gutteridge, et al.
Clinical Endocrinology|March 1, 1991
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesA J Fenton, D H Gutteridge, G N Kent, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodiumR I Price, D H Gutteridge, B G Stuckey, et al.
Seminars in Arthritis and Rheumatism|February 1, 1994
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severityB G Stuckey, D H Gutteridge, G O Stewart, et al.
Bone|October 1, 1996
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year studyD H Gutteridge, R W Retallack, L C Ward, et al.
Bone|February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical boneD H Gutteridge, R W Retallack, L C Ward, et al.
Pageof 5